Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Alterations in Muscle Tone lll

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A fat chance at neuroprotection: Ketogenic diet and Parkinson's disease.

Clinical nutrition ESPEN·2026

Same author

Prospective longitudinal observational study at an academic medical centre of lifestyle and cognition in older adults with a cochlear implant or hearing aid: study protocol.

BMJ open·2026

Same author

Effects of Age and Cognitive Impairment on PROMIS-57 Profile Responses: Qualitative Analyses from Cognitive Interviews.

Advances in patient-reported outcomes·2026

Same author

Recruitment strategies for the racial disparities in Parkinson's disease study: Partnering with patients from the Black community.

Parkinsonism & related disorders·2026

Same author

Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations.

Brain : a journal of neurology·2025

Same author

Longitudinal patterns of loss of independence in Parkinson disease.

Neurodegenerative disease management·2025

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

Understanding disability in Parkinson's disease.

Lisa M Shulman¹

¹Department of Neurology, University of Maryland School of Medicine, Baltimore, Maryland 21210, USA. lshulman@som.umaryland.edu

Movement Disorders : Official Journal of the Movement Disorder Society

|February 27, 2010

Summary

This summary is machine-generated.

Parkinson's disease (PD) symptoms inevitably worsen, causing disability. This review clarifies the link between PD impairments and disability, aiding in functional limitation management.

More Related Videos

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Related Experiment Videos

Last Updated: Jun 15, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Area of Science:

Neurology
Clinical Medicine
Rehabilitation Science

Background:

Parkinson's disease (PD) is a progressive neurodegenerative disorder.
Despite optimal therapy, PD symptoms inevitably advance, leading to functional disability.
Minimizing disability and preserving daily activity performance are key clinical goals.

Purpose of the Study:

To differentiate between impairment, disability, and quality of life in PD.
To explore the relationship between specific PD impairments and resultant disability.
To review tools for measuring outcomes and challenges in assessing PD disability.

Main Methods:

Literature review and conceptual analysis.
Exploration of the PD symptom-disability continuum.
Discussion of measurement tools and assessment impediments.

Main Results:

PD impairments directly contribute to functional disability.
Clear distinctions exist between impairment, disability, and quality of life.
Accurate disability assessment is crucial but faces challenges.

Conclusions:

Understanding the PD impairment-disability link is vital for clinical management.
Effective strategies require differentiating impairments from functional limitations.
Improved assessment tools and methods are needed to track and manage PD disability.